[1] 谢建平. 电子烟相关技术与法律监管[C]//中国烟草学会2014年学术年会. 北京, 2014-12-23. Xie Jianping. E-cigarette technology and legal supervision[C]//The Chi-nese Society of Tobacco in 2014 Academic Conference. Beijing, Dec 23, 2014.
[2] 李保江. 全球电子烟市场发展、主要争议及政府管制[J]. 中国烟草学报, 2014, 20(4):101-107. Li Baojiang. Electronic cigarette development, the main issues and gov-ernment regulation in global market[J]. Acta Tabacaria Sinica, 2014, 20(4):101-107.
[3] Henningfield J E, Zaatari G S. Electronic nicotine delivery systems:emerging science foundation for policy[J]. Tobacco Control, 2010, 19(19):89-90.
[4] Dawkins L, Concoran O. Acute electronic cigarette use:nicotine deliv-ery and subjective effects in regular users[J]. Psychopharmacology, 2014, 231(2):401-407.
[5] Jasinska A J, Zorick T, Brody A L, et al. Dual role of nicotine in addic-tion and cognition:A review of neuroimaging studies in humans[J]. Neu-ropharmacology, 2014, 84(1):111-122.
[6] Goniewicz M L, Kuma T, Gawron M, et al. Nicotine levels in electronic cigarettes[J]. Nicotine Tobacco Research, 2012, 15(1):158-166.
[7] McAuley T R, Hopke P K, Zhao J, et al. Comparison of the effects of ecigarette vapor and cigarette smoke on indoor air quality Inhalation Toxicology[J]. Inhalation Toxicology, 2012, 24(12):850-857.
[8] Phillips D H. DNA adducts as markers of exposure and risk[J]. Muta-tion Research/Fundamental and Molecular Mechanisms of Mutagenesis, 2005, 577(1/2):284-292.
[9] Hang B, Chenna A, Rao S, et al. 1, N6-ethenoadenine and 3, N4-ethe-nocytosine are excised by separate human DNA glycosylases[J]. Carci-nogenesis, 1996, 17(1):155-157.
[10] Petronzelli F, Riccio A, Markham G D, et al. Biphasic kinetics of the human DNA repair protein MED1(MBD4), a mismatch-specific DNA N-Glycosylase[J]. Journal of Biological Chemistry, 2000, 275(42):32422-32429.
[11] Shen M, Bin P, Li H-B, et al. Increased levels of etheno-DNA ad-ducts and genotoxicity biomarkers of long-term exposure to pure die-sel engine exhaust[J]. Science of the Total Environment, 2016, 543:267-273.
[12] Ghissassi F, Barbin A, Nair J, et al. Formation of 1, N6-ethenoadenine and 3, N4-ethenocytosine by lipid peroxidation products and nucleic acid bases[J]. Chemical Research in Toxicology, 1995, 8(2):278-283.
[13] Wang Y, Millonig G, Nair J, et al. Ethanol-induced cytochrome P4502E1 causes carcinogenic etheno-DNA lesions in alcoholic liver dis-ease[J]. Hepatology, 2009, 50(2):453-461.
[14] Seitz H K, Stickel F. Risk factors and mechanisms of hepatocarcino-genesis with special emphasis on alcohol and oxidative stress[J]. Bio-logical Chemistry, 2006, 387(4):349-360.
[15] You S J, Wang J S, Dai X X, et al. Transcriptional inhibition and mu-tagenesis induced by N-nitroso compound-derived carboxymethylated thymidine adducts in DNA[J]. Nucleic Acids Research, 2015, 43(2):1012-1018.
[16] Kim H, Shin H. Determination of tobacco-specific nitrosamines in re-placement liquids of electronic cigarettes by liquid chromatographytandem mass spectrometry[J]. Journal of Chromatography A, 2013, 1291(2):48-55.
[17] Chen H J, Lee C R. Detection and simultaneous quantification of three smoking-related ethylthymidine adducts in human salivary DNA by liquid chromatography tandem mass spectrometry[J]. Toxicology Letters, 2014, 224(1):101-107.
[18] Conney A H, Chang I L, Jerina D M, et al.Studies on the metabo-lism of benzo[a]pyrene and dose-dependent differences in the profile of its ultimate carcinogenic metabolite[J]. Drug Metabolism Reviews, 1994, 26(1/2):125-163.
[19] Shimada T, Gillam E M, Oda Y, et al. Metabolism of Benzo[a]pyrene to trans-7, 8-Dihydroxy-7, 8-dihydrobenzo[a]pyrene by Recombinant Human Cytochrome P4501B1 and Purified Liver Epoxide Hydrolase[J]. Chemical Research Toxicology, 1999, 12(7):623-629.
[20] Nesnow S, Davis C, Nelson G B, et al. Comparison of the genotoxic ac-tivities of the K-region dihydrodiol of benzo[a]pyrene with benzo[a]py-rene in mammalian cells:morphological cell transformation; DNA dam-age; and stable covalent DNA adducts[J]. Mutation Research, 2002, 521(1-2):91-102.
[21] Dipple A. Formation, metabolism, and mechanism of action of polycy-clic aromatic hydrocarbons[J]. Cancer Research, 1983, 43(Suppl 5):2422-2425.
[22] Jeffrey A M, Jennette K W, Blohstein S H, et al. Benzo[a]pyrene-nu-cleic acid derivative found in vivo:structure of a benzo[a]pyrenetetra-hydrodiol epoxide-guanosine adduct[J]. ChemInform, 1976, 98(48):5714-5715.
[23] Denissenko M F, Pan A, Tang M, et al. Preferential formation of benzo[a]pyrene Adducts at lung cancer mutational hotspots in P53[J]. Science, 1996, 274(5286):430-432.
[24] Rugged B, Dirado M, Zhang S Y, et al. Benzo[a]pyrene-induced mu-rine skin tumors exhibit frequent and characteristic G to T mutations in the p53 gene[J]. PNAS, 1993, 90(3):1013-1017.
[25] Hhsgafvel-pttriainen K, Ridanpaa M, Anttila S, et al. p53 and ras gene mutations in lung cancer:implications for smoking and occupa-tional exposures[J]. Journal of Occupational and Environmental Medi-cine, 1995, 37(1):69-76.
[26] Ross J A, Nesnow S. Polycyclic aromatic hydrocarbons between DNA adducts and ras oncogene mutations[J]. Mutation Research, 1999, 424(1/2):155-166.
[27] Marshall C J, Vousden K H, Phillips D H. Activation of c-Ha-ras-1 proto-oncogene by in vitro modification with a chemical carcinogen, benzo(a)pyrene diolepoxide[J]. Nature, 1984, 310(5978):586-589.
[28] Pfeifer G P, Denissenko M F, Olivier M, et al. Tobacco smoke carcino-gens, DNA damage and p53 mutations in smoking-associated cancers[J]. Oncogene, 2002, 21(48):7435-7451.
[29] Hecht S S, Carmella B S, Kotandeniya D, et al. Evaluation of toxicant and carcinogen metabolites in the urine of E-Cigarette users versus cigarette smokers[J]. Nicotine & Tobacco Research, 2015, 17(6):704-709.
[30] Ambrose J Z, Barua R S. The pathophysiology of cigarette smoking and cardiovascular disease:An update[J]. Journal of the American Col-lege of Cardiology, 2004, 43(10):1731-1737.
[31] Dawkins L, Turnern J, Roberys A, et al.‘Vaporing’ profiles and pref-erences:an online survey of electronic cigarette users[J]. Addiction, 2013, 108(6):1115-1125.
[32] Dawkins L, Concoran O. Acute electronic cigarette use:nicotine deliv-ery and subjective effects in regular users[J]. Psychopharmacology, 2014, 231(2):401-407.
[33] Vansickel A R, Eissenberg T. Electronic cigarettes:Effective nicotine delivery after acute administration[J]. Nicotine Tobacco Research, 2013, 15(1):267-270.
[34] Hukkanen J, Jacob P, Benowitz N L. metabolism and disposition kinet-ics of nicotine[J]. Pharmacological Reviews, 2005, 57(1):79-115.
[35] Etter J F, Bullen C. Salvia cotinine levels in users of electronic ciga-rettes[J]. European Respiratory Journal, 2011, 38(5):1219-1220.
[36] Etter J, Bullen C. Electronic cigarette:users profile, utilization, satis-faction and perceived efficacy[J]. Addiction, 2011, 106(11):2017-2028.
[37] Flouris A D, Chorti M S, Poulianiti K P, et al. Acute impact of active and passive electronic cigarette smoking on serum cotinine and lung function[J]. Inhalation Toxicology, 2013, 25(2):91-101.
[38] Laugesen M. Safety report on the Ruyan® e-cigarette cartridge and inhaled Aerosol[R]. 2015-09-06. http://www.healthnz.co.nz/RuyanCar-tridgeReport30-Oct-08.pdf. 2008.
[39] Westenberer B. Evaluation of e-Cigarettes. St. Louis, MO:Department of health and human services, food and drug administration, center for drug evaluation and research[R]. Division of Pharmaceutical Analysis. 2015-09-06. http://www.fda.gov/downloads/drugs/Scienceresearch/UCM173250.pdf.2013.
[40] Kim H, Shin H. Determination of tobacco-specific nitrosamines in re-placement liquids of electronic cigarettes by liquid chromatographytandem mass spectrometry[J]. Journal of Chromatography A, 2013, 1291(2):48-55.
[41] Bahl V, Lin S, Xu N, et al. Comparison of electronic cigarette refill fluid cytotoxicity using embryonic and adult models[J]. Reproductive Toxicology, 2012, 34(4):529-537.
[42] Hecht S S, Carmella B S, Kotandeniya D, et al. Evaluation of toxicant and carcinogen metabolites in the urine of E-Cigarette users versus cigarette smokers[J]. Nicotine & Tobacco Research, 2015, 17(6):704-709.
[43] Toyokuni S. Iron and carcinogenesis:from Fenton reaction to target genes[J]. Redox Report, 2002, 7(4):189-196.
[44] Romagna G, Allifranchini E, Bocchietto E, et al. Cytotoxicity evalua-tion of electronic cigarette vapor extract on cultured mammalian fibro-blasts (ClearStream-LIFE):Comparison with tobacco cigarette smoke extract[J]. Inhalation Toxicology, 2013, 25(6):354-361.
[45] Behar R, Davis B, Wang Y, et al. Identification of toxicants in cinna-mon-flavored electronic cigarette refill fluids[J]. Toxicology In Vitro, 2014, 28:198-208.
[46] Robertson O, Loosli C, Puck T, et al. Tests for the chronic toxicity of propylene glycol and triethylene glycol on monkeys and rats by vapor inhalation and oral administration[J]. Journal of Pharmacology and Ex-perimental Therapeutics, 1947, 131(91):52-76.
[47] Werley M, McDonald P, Lilly P, et al. Non-clinical safety and pharma-cokinetic evaluations of propylene glycol aerosol in Sprague-Dawley rats and Beagle dogs[J]. Toxicology, 2011, 287(1-3):76-90.
[48] Wieslander G, Norback D, Lindgren T. Experimental exposure to pro-pylene glycol mist in aviation emergency training:Acute ocular and re-spiratory effects[J]. Occupational and Environmental Medicine, 2001, 58(10):649-655.
[49] Czekaj P, Palasz A, Lebda-wyborny T, et al. Morphological changes in lungs, placenta, liver and kidneys of pregnant rats exposed to ciga-rette smoke[J]. International Archives of Occupational and Environ-mental Health, 2002, 75(1):S27-S35.
[50] Polosa R, Morjaria J, Caponnetto P, et al. Effectiveness and tolerabili-ty of electronic cigarette in real-life:A 24-month prospective observa-tional study[J]. Internal and Emergency Medicine, 2014, 9(5):537-546.
[51] Farsalinos K, Romagna G, Tsiapras D, et al. Evaluating nicotine levels selection and patterns of electronic cigarette use in a group of "vapers"who had achieved complete substitution of smoking[J]. Subst Abuse, 2013, 7(7):139-146.
[52] Dawkins L. Electronic cigarettes:what are they and are they effective? E-Cigarette Summit, London, UK[R].[2015-09-01]. http://e-ciga-rette-summit.com/wp-content/uploads/2013/12/Summit-Presentations. pdf.2013.
[53] Etter J, Bullen C. Electronic cigarette:Users profile, utilization, satis-faction and perceived efficacy[J]. Addiction, 2011, 106(11):2017-2028.
[54] Vardavas C, Anagnostopoulos N, Kougias M, et al. Short-term pulmo-nary effects of using an electronic cigarette:Impact on respiratory flow resistance, impedance, and exhaled nitric oxide[J]. Chest, 2012, 141(6):1400-1406.
[55] Farsalinos K, Tsiapras D, Kyrzopouios S, et al. Acute effects of using an electronic nicotine-delivery device (e-cigarette) on myocardial function:comparison with the effects of regular cigarettes[J]. BMC Car-diovascular Disorders, 2014, 14(1):1-10.
